로딩 중...
52주 최고가 대비 94.8% 위치
908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; XplorIR, a handheld device that uses FTIR spectroscopy to identify, quantify, and track gases and vapors; ThreatID, a portable FTIR device that rapidly detects and identifies approximately 28,000 unknown gas, vapor, powder, and liquid chemical hazards; ProtectIR, a handheld FTIR device that can identify approximately 23,000 solid and liquid chemical hazards; and VipIR, a handheld 3-in-1 analyzer that integrates FTIR, Raman spectroscopy, and smart spectral processing (SSP), a proprietary algorithm, to provide a single result from just one sample. It operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of Americas. The company was incorporated in 2012 and is headquartered in Burlington, Massachusetts.
SEC 13F 공시 기준 · 2026-Q1
SEC 13F 공시 기준 데이터입니다. 실제 현재 보유 현황과 다를 수 있으며, 투자 자문·권유·추천이 아닙니다.
| 재무 항목 | 2021년 | 2022년 | 2023년 | 2024년 | 2025년 |
|---|---|---|---|---|---|
| 주요 재무실적 (USD) | |||||
| 매출액 | - | $46.9M | $50.2M | $47.7M | $56.2M |
| 영업이익 | - | $-35.4M | $-42.7M | $-29.9M | $-25.7M |
| 당기순이익 | - | $-33.6M | $-36.4M | $-72.2M | $19.5M |
| 잉여현금흐름 (FCF) | - | $-23.0M | $-27.1M | $-30.8M | $-24.6M |
| 수익성 비율 | |||||
| 영업이익률 | - | -75.5% | -84.9% | -62.7% | -45.7% |
| 순이익률 | - | -71.6% | -72.5% | -151.2% | 34.7% |
| ROE (자기자본이익률) | - | -17.6% | -22.0% | -63.0% | 13.6% |
| ROA (자산이익률) | - | -13.8% | -17.9% | -45.3% | 10.3% |
| 성장성 비율 | |||||
| 매출 성장률 (YoY) | - | - | 7.2% | -4.9% | 17.7% |
| EPS 성장률 (YoY) | - | -35.4% | -5.6% | -87.6% | - |
| 투자 지표 & 가치배수 | |||||
| PER (주가수익배수) | - | - | - | - | - |
| PBR (주가순자산배수) | - | 1.8x | 1.6x | 0.8x | 1.7x |
| PSR (주가매출배수) | - | 7.5x | 5.3x | 2.0x | 4.2x |
| FCF Yield | - | -6.5% | -10.1% | -32.6% | -10.3% |
| 재무 건전성 (안정성) | |||||
| 부채비율 (D/E) | - | 0.10 | 0.04 | 0.04 | 0.03 |
| 유동비율 | - | 11.22 | 7.71 | 4.10 | 4.24 |
MOLINA HEALTHCARE INC
$179.86
$9.4B